✦ LIBER ✦

Swallow recovery in an oral cancer patient following surgery, radiotherapy, and hyperthermia

✍ Scribed by Dr. Cathy L. Lazarus; Dr. Jeri A. Logemann; Dr. Peter J. Kahrilas; Dr. Bharat B. Mittal

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 623 KB
Volume: 16
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.2880160309

No coin nor oath required. For personal study only.

✦ Synopsis

Background. No study has examined the nature and extent of swallowing impairment in oral cancer patients following treatment with combined hyperthermia and interstitial radiotherapy. Few studies have examined the effects of voluntary swallow maneuvers (supersupraglottic and Mendelsohn) on pharyngeal phase swallowing in the oral cancer patient treated with surgery or radiotherapy. This study examined the effects of combined radiotherapeutic salvage treatments of hyperthermia and interstitial implantation and swallow recovery using swallow maneuvers in a surgically treated and irradiated oral cancer patient.

Methods. The patient under study, a 51-year-old man, underwent radiotherapy, according to Radiation Therapy Oncology Group (RTOG) protocol #8419, consisting of a combination of interstitial irradiation and hyperthermia to the base of tongue, for a recurrent squamous cell cancer. He underwent videofluorographic (VFG) examination of his swallowing, a modified barium swallow at three time points: 2 days following radiotherapy treatment (VFGl), 4 weeks later (VFG2), and 8 months later (VFG3). Temporal and bio-From the

📜 SIMILAR VOLUMES

Effects of radiotherapy with or without

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer

✍ Cathy Lazarus; Jeri A. Logemann; Barbara Roa Pauloski; Alfred W. Rademaker; Iren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract ## Background. Oral tongue strength and swallowing ability are reduced in patients treated with chemoradiotherapy for oral and oropharyngeal cancer. ## Methods. Patients with oral or oropharyngeal cancer treated with high‐dose chemoradiotherapy underwent tongue strength, swallowing,

The fate of osseointegrated implants in

The fate of osseointegrated implants in patients following oral cancer surgery and mandibular reconstruction

✍ Adorján F. Kovács 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Background. The feasibility of implant treatment in patients after oral ablative tumor surgery and defect reconstruction has not yet been investigated in terms of the requisite high standards of success assessment. A report on this topic must address not only implant survival but implant health, bon

Relationship between swallow motility di

Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy

✍ Barbara Roa Pauloski; Alfred W. Rademaker; Jerilyn A. Logemann; Lisa Newman; Ell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Background: Current research demonstrates that swallow function is impaired after treatment with organ-sparing chemoradiotherapy. few studies, however, have related observed swallowing disorders with the patient's oral intake and diet in a large cohort of patients. ## Methods: Swallowing funct

Long-term survival in locally advanced o

Long-term survival in locally advanced oral cavity cancer: An analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery

✍ Enzo Maria Ruggeri; Paolo Carlini; Camillo Francesco Pollera; Salvatore De Marco 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

## Background: Neoadjuvant chemotherapy has been reported to be extremely active in head and neck cancer but has failed to give a statistically significant improvement in survival. ## Methods: From 1981 to 1994, 33 operable patients with locally advanced oral cavity cancer received cisplatin-base

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views